Posted: 31 May 10
Edited: 8 Aug 18
Audits Eye, Ear, Nose and Throat
Beclometasone is our first line treatment for prophylaxis and treatment of allergic and perennial rhinitis.
Avamys is currently more cost effective than other second line agents in particular Flixonase.
This protocol provides a structure for the switch from Flixonase to Avamys.